[{"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-001", "question": "A 4-year-old boy presents with recurrent bacterial infections since infancy, including pneumonia and otitis media. Laboratory evaluation reveals absent CD19+ B cells, normal T cell numbers with preserved proliferation to mitogens, and undetectable serum immunoglobulins. Genetic testing identifies a mutation in a cytoplasmic tyrosine kinase essential for B cell development. His 2-year-old brother is asymptomatic but has the same mutation. Which of the following best explains the brother's lack of clinical manifestations?", "options": ["Residual maternal IgG providing passive immunity", "Somatic mosaicism with partial gene function restoration", "Compensatory upregulation of alternative signaling pathways", "X-chromosome inactivation favoring the wild-type allele", "Presence of a hypomorphic rather than null mutation"], "answer": "A", "answer_index": 0, "explanation": "This case describes X-linked agammaglobulinemia (XLA) due to BTK mutation. At age 2, the asymptomatic brother may still have residual transplacentally acquired maternal IgG, which typically wanes by 6-9 months but can persist longer in some cases, providing temporary protection. X-chromosome inactivation is irrelevant as this is an X-linked recessive condition affecting males who have only one X chromosome. Somatic mosaicism and hypomorphic mutations would show some B cell development, which is absent here.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: N (No answer defensible). Verdict: No option can be defended as uniquely correct. This vignette describes X-linked agammaglobulinemia (XLA). The key discriminating clue is the asymptomatic 2-year-old brother with the same BTK mutation. Option A (residual maternal IgG) is medically inaccurate: maternal IgG wanes by 6-9 months and cannot explain lack of symptoms at age 2. Options B and E could explain variable expressivity but are unsupported by the stem's description of a null phenotype (absent B cells, undetectable Ig) in the proband. Option D is genetically incorrect for males, and C is biologically implausible. The item lacks critical data (brother's labs, mutation type) needed to identify a plausible mechanism. Medical accuracy is compromised by the fundamental error regarding passive immunity duration. Minimal fix: Change brother's age to <9 months to justify A, or revise key to B/E with added data showing partial immune function in the younger sibling.\",\"medical_accuracy_score\":   \"2\",\"logical_validity\": false,\"logical_false_reason\": \"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: N (No answer defensible). Verdict: No option can be defended as uniquely correct. This vignette describes X-linked agammaglobulinemia (XLA). The key discriminating clue is the asymptomatic 2-year-old brother with the same BTK mutation. Option A (residual maternal IgG) is medically inaccurate: maternal IgG wanes by 6-9 months and cannot explain lack of symptoms at age 2. Options B and E could explain variable expressivity but are unsupported by the stem's description of a null phenotype (absent B cells, undetectable Ig) in the proband. Option D is genetically incorrect for males, and C is biologically implausible. The item lacks critical data (brother's labs, mutation type) needed to identify a plausible mechanism. Medical accuracy is compromised by the fundamental error regarding passive immunity duration. Minimal fix: Change brother's age to <9 months to justify A, or revise key to B/E with added data showing partial immune function in the younger sibling.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-002", "question": "A 58-year-old woman with metastatic melanoma receiving combination ipilimumab and nivolumab develops acute onset confusion, fever to 39.2°C, and neck stiffness on day 21 of treatment. CSF analysis shows 180 WBC/μL (92% lymphocytes), protein 156 mg/dL, glucose 52 mg/dL (serum 98 mg/dL), and negative Gram stain. MRI brain shows leptomeningeal enhancement. CSF cytology and flow cytometry are negative for malignant cells. Which additional CSF finding would most strongly support the diagnosis of immune checkpoint inhibitor-induced aseptic meningitis over infectious or neoplastic etiologies?", "options": ["Elevated CSF adenosine deaminase level", "Presence of oligoclonal bands with matched serum bands", "Markedly elevated CSF IL-17 levels", "CD4+/CD8+ T cell ratio greater than 4:1 with activated phenotype", "Elevated CSF beta-2 microglobulin"], "answer": "D", "answer_index": 3, "explanation": "Immune checkpoint inhibitor-induced aseptic meningitis characteristically shows a CD4+ predominant lymphocytic pleocytosis with activated T cell phenotype (expressing HLA-DR, CD69), reflecting the mechanism of enhanced T cell activation. Elevated ADA suggests tuberculosis; oligoclonal bands suggest MS or infectious processes; elevated IL-17 is nonspecific; beta-2 microglobulin elevation occurs in lymphomatous meningitis. The CD4+/CD8+ ratio with activation markers specifically reflects the immunologic mechanism of checkpoint inhibitor toxicity.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: K (Miskeyed). Verdict: The keyed answer is not defensible based on current evidence. Key clues: ICI therapy, lymphocytic pleocytosis, negative cytology, need to exclude infection/malignancy. The question asks for a CSF finding that distinguishes ICI-induced aseptic meningitis. While option D attempts to identify an immune-mediated signature, the specific CD4+/CD8+ ratio >4:1 is not a validated diagnostic biomarker in ICI neurotoxicity. This ratio is not established in major guidelines or large studies as distinguishing ICI-induced meningitis from infectious or neoplastic etiologies. Options A, B, C, and E are appropriately excluded as they suggest TB (A), nonspecific inflammation (B, C), or lymphoma (E). However, D presents a fabricated specificity. Medical accuracy is compromised by teaching a non-evidence-based diagnostic criterion. Logical validity fails because the answer key relies on this inaccurate premise. Minimal fix: Replace option D with 'CSF pleocytosis with activated T cells and exclusion of infectious/neoplastic markers by full workup' to reflect that diagnosis relies on exclusion rather than a specific ratio.\",\"medical_accuracy_score\":    \"2\",\"logical_validity\": false,\"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). Verdict: The keyed answer is not defensible based on current evidence. Key clues: ICI therapy, lymphocytic pleocytosis, negative cytology, need to exclude infection/malignancy. The question asks for a CSF finding that distinguishes ICI-induced aseptic meningitis. While option D attempts to identify an immune-mediated signature, the specific CD4+/CD8+ ratio >4:1 is not a validated diagnostic biomarker in ICI neurotoxicity. This ratio is not established in major guidelines or large studies as distinguishing ICI-induced meningitis from infectious or neoplastic etiologies. Options A, B, C, and E are appropriately excluded as they suggest TB (A), nonspecific inflammation (B, C), or lymphoma (E). However, D presents a fabricated specificity. Medical accuracy is compromised by teaching a non-evidence-based diagnostic criterion. Logical validity fails because the answer key relies on this inaccurate premise. Minimal fix: Replace option D with 'CSF pleocytosis with activated T cells and exclusion of infectious/neoplastic markers by full workup' to reflect that diagnosis relies on exclusion rather than a specific ratio.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-003", "question": "A 6-month-old infant presents with progressive hypotonia, poor feeding, and developmental regression over 2 weeks. Parents report a recent upper respiratory infection. Examination reveals absent deep tendon reflexes, tongue fasciculations, and paradoxical breathing. EMG shows fibrillation potentials and reduced motor unit recruitment. Genetic testing for SMN1 deletions is negative. CSF protein is markedly elevated at 280 mg/dL. Which of the following is the most likely diagnosis?", "options": ["Infantile-onset Pompe disease", "Acute motor axonal neuropathy variant of Guillain-Barré syndrome", "Spinal muscular atrophy type 1 with atypical genetics", "Infantile botulism", "Cytomegalovirus-associated polyradiculopathy"], "answer": "B", "answer_index": 1, "explanation": "The combination of acute/subacute onset following infection, areflexia, tongue fasciculations (cranial nerve involvement), paradoxical breathing, EMG showing denervation, and markedly elevated CSF protein with albuminocytologic dissociation strongly suggests acute motor axonal neuropathy (AMAN), a GBS variant. SMA type 1 would have positive SMN1 testing in >95% of cases and insidious onset. Infantile botulism shows decremental response on repetitive stimulation and normal CSF. Pompe disease shows myopathic EMG changes. CMV polyradiculopathy typically occurs in immunocompromised patients.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. The vignette uniquely supports acute motor axonal neuropathy (AMAN) variant of GBS as the single best answer. Key discriminators include subacute onset (2 weeks) following URI, absent DTRs, marked CSF protein elevation (280 mg/dL) indicating albuminocytologic dissociation, and EMG evidence of acute denervation. While tongue fasciculations are more classically associated with SMA type 1, they can occur with hypoglossal nerve involvement in severe GBS; negative SMN1 testing and acute progression appropriately exclude SMA. Infantile botulism is inconsistent with elevated CSF protein and would show decremental response on repetitive stimulation. Pompe disease demonstrates myopathic rather than neuropathic features. CMV polyradiculopathy typically affects immunocompromised patients. The keyed answer is medically accurate and aligns with current GBS diagnostic criteria, though infantile GBS remains rare. No contradictions or underspecification preclude a unique best answer. Minimal fix: specify 'tongue weakness with occasional fasciculations' to reduce potential ambiguity.\",\"medical_accuracy_score\":   \t\"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. The vignette uniquely supports acute motor axonal neuropathy (AMAN) variant of GBS as the single best answer. Key discriminators include subacute onset (2 weeks) following URI, absent DTRs, marked CSF protein elevation (280 mg/dL) indicating albuminocytologic dissociation, and EMG evidence of acute denervation. While tongue fasciculations are more classically associated with SMA type 1, they can occur with hypoglossal nerve involvement in severe GBS; negative SMN1 testing and acute progression appropriately exclude SMA. Infantile botulism is inconsistent with elevated CSF protein and would show decremental response on repetitive stimulation. Pompe disease demonstrates myopathic rather than neuropathic features. CMV polyradiculopathy typically affects immunocompromised patients. The keyed answer is medically accurate and aligns with current GBS diagnostic criteria, though infantile GBS remains rare. No contradictions or underspecification preclude a unique best answer. Minimal fix: specify 'tongue weakness with occasional fasciculations' to reduce potential ambiguity.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-004", "question": "A 45-year-old man with acute myeloid leukemia undergoes allogeneic hematopoietic stem cell transplantation. On day +14, he develops fever, hypoxemia, and diffuse pulmonary infiltrates. Bronchoalveolar lavage shows hemorrhagic return with progressively bloodier aliquots. DAD is seen on transbronchial biopsy. Galactomannan, beta-D-glucan, and respiratory viral panel are negative. He is on tacrolimus with therapeutic levels. Which of the following findings would most strongly support a diagnosis of diffuse alveolar hemorrhage due to transplant-associated thrombotic microangiopathy rather than idiopathic pneumonia syndrome?", "options": ["Elevated serum lactate dehydrogenase with schistocytes on peripheral smear", "Presence of hemosiderin-laden macrophages in BAL fluid", "Concurrent acute kidney injury with proteinuria", "Elevated plasma-free hemoglobin with decreased haptoglobin", "Refractory thrombocytopenia despite platelet transfusions"], "answer": "E", "answer_index": 4, "explanation": "Transplant-associated thrombotic microangiopathy (TA-TMA) characteristically shows refractory thrombocytopenia that fails to increment appropriately with platelet transfusions due to ongoing platelet consumption in microthrombi. While elevated LDH, schistocytes, and decreased haptoglobin occur in both TA-TMA and other hemolytic processes, and AKI can occur in multiple post-transplant complications, the specific finding of platelet refractoriness distinguishes TA-TMA. Hemosiderin-laden macrophages simply confirm alveolar hemorrhage without indicating etiology. Idiopathic pneumonia syndrome does not cause platelet refractoriness.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"Validity: K (Miskeyed). Verdict: Miskeyed; unique best answer exists but key is incorrect. Key stem clues: post-allogeneic HSCT day +14, DAH with hemorrhagic BAL and DAD, negative infectious workup. The question asks for the finding that most strongly supports TA-TMA over IPS as the cause of DAH. Option A (schistocytes) provides pathognomonic evidence of microangiopathic hemolysis, the defining pathophysiologic feature of TA-TMA, directly implicating this diagnosis. Option E (refractory thrombocytopenia) is characteristic of TA-TMA but less specific, as thrombocytopenia with poor transfusion response also occurs in engraftment syndrome, sepsis with DIC, GVHD, and drug toxicity. The explanation contains medical inaccuracy: schistocytes are specific for MAHA and not seen in immune or other hemolytic processes. This error undermines the rationale for preferring E over A. Minimal fix: Change correct answer to A and revise explanation to emphasize that schistocytes provide pathognomonic evidence of microangiopathy, making them the most specific discriminator.\",\"medical_accuracy_score\":   \t\"3\",\"logical_validity\": false,\"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). Verdict: Miskeyed; unique best answer exists but key is incorrect. Key stem clues: post-allogeneic HSCT day +14, DAH with hemorrhagic BAL and DAD, negative infectious workup. The question asks for the finding that most strongly supports TA-TMA over IPS as the cause of DAH. Option A (schistocytes) provides pathognomonic evidence of microangiopathic hemolysis, the defining pathophysiologic feature of TA-TMA, directly implicating this diagnosis. Option E (refractory thrombocytopenia) is characteristic of TA-TMA but less specific, as thrombocytopenia with poor transfusion response also occurs in engraftment syndrome, sepsis with DIC, GVHD, and drug toxicity. The explanation contains medical inaccuracy: schistocytes are specific for MAHA and not seen in immune or other hemolytic processes. This error undermines the rationale for preferring E over A. Minimal fix: Change correct answer to A and revise explanation to emphasize that schistocytes provide pathognomonic evidence of microangiopathy, making them the most specific discriminator.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-005", "question": "A 3-year-old girl presents with acute onset right-sided weakness and slurred speech. CT head is negative for hemorrhage. MRI reveals acute left middle cerebral artery territory infarction. Echocardiogram shows no structural abnormalities or vegetations. Hypercoagulability workup including protein C, protein S, antithrombin III, factor V Leiden, and prothrombin gene mutation are normal. Hemoglobin electrophoresis is normal. She had chickenpox 6 weeks ago. Cerebral angiography shows focal stenosis of the left distal internal carotid artery with a \"beaded\" appearance. Which of the following is the most appropriate long-term management?", "options": ["Lifelong warfarin anticoagulation", "Aspirin therapy for 2 years with serial vascular imaging", "Immediate surgical bypass of the stenotic segment", "High-dose intravenous immunoglobulin monthly", "Indefinite dual antiplatelet therapy with aspirin and clopidogrel"], "answer": "B", "answer_index": 1, "explanation": "This presentation is classic for post-varicella arteriopathy (transient cerebral arteriopathy), which causes focal stenosis of large intracranial arteries following VZV infection. The condition is typically monophasic and self-limiting, with arterial changes stabilizing or improving over 6-24 months. Current guidelines recommend aspirin therapy for approximately 2 years with serial vascular imaging to monitor for progression or resolution. Anticoagulation is not superior to antiplatelet therapy and carries higher bleeding risk. Surgical bypass is not indicated for this typically self-resolving condition. IVIG has no established role in post-varicella arteriopathy.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. Key discriminating clues—3-year-old with acute left MCA infarction, recent varicella infection (6 weeks), beaded stenosis of distal ICA on angiography, and negative hypercoagulability workup—establish post-varicella arteriopathy (transient cerebral arteriopathy). Current AHA/ASA pediatric stroke guidelines recommend aspirin (1–2 mg/kg/day) for approximately 2 years with serial vascular imaging to monitor resolution, matching option B. Alternative analysis: A (lifelong warfarin) is inappropriate for this monophasic, self-limiting arteriopathy and carries higher bleeding risk; C (surgical bypass) is not first-line for a condition that typically resolves; D (monthly IVIG) lacks evidence; E (indefinite dual antiplatelet) exceeds guideline recommendations without added benefit. No logical flaws: vignette provides sufficient detail for a single best answer, and the key is correct. Medical accuracy is gold-standard—content aligns with current consensus, presents a realistic pediatric stroke scenario, and tests appropriate therapeutic decision-making. No revisions needed.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key discriminating clues—3-year-old with acute left MCA infarction, recent varicella infection (6 weeks), beaded stenosis of distal ICA on angiography, and negative hypercoagulability workup—establish post-varicella arteriopathy (transient cerebral arteriopathy). Current AHA/ASA pediatric stroke guidelines recommend aspirin (1–2 mg/kg/day) for approximately 2 years with serial vascular imaging to monitor resolution, matching option B. Alternative analysis: A (lifelong warfarin) is inappropriate for this monophasic, self-limiting arteriopathy and carries higher bleeding risk; C (surgical bypass) is not first-line for a condition that typically resolves; D (monthly IVIG) lacks evidence; E (indefinite dual antiplatelet) exceeds guideline recommendations without added benefit. No logical flaws: vignette provides sufficient detail for a single best answer, and the key is correct. Medical accuracy is gold-standard—content aligns with current consensus, presents a realistic pediatric stroke scenario, and tests appropriate therapeutic decision-making. No revisions needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-006", "question": "A 62-year-old man with small cell lung cancer develops progressive proximal weakness over 3 months. He has difficulty rising from chairs and climbing stairs. Examination reveals proximal muscle weakness (3/5), preserved reflexes, and no sensory deficits. CK is 4,200 U/L. EMG shows myopathic changes with fibrillation potentials. Muscle biopsy reveals necrotic and regenerating fibers with minimal inflammatory infiltrate. Testing for anti-Jo-1, anti-Mi-2, anti-SRP, and anti-MDA5 antibodies is negative. Which antibody is most likely to be positive in this patient?", "options": ["Anti-HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase)", "Anti-TIF1-gamma (transcription intermediary factor 1-gamma)", "Anti-NXP-2 (nuclear matrix protein 2)", "Anti-SAE (small ubiquitin-like modifier activating enzyme)", "Anti-HMGCR antibodies with concurrent anti-SRP positivity"], "answer": "B", "answer_index": 1, "explanation": "Anti-TIF1-gamma antibodies are strongly associated with malignancy-associated dermatomyositis/inflammatory myopathy, particularly in adults over 40 with underlying cancer. Small cell lung cancer is a known associated malignancy. The biopsy showing necrotizing features with minimal inflammation is consistent with immune-mediated necrotizing myopathy, which can occur with TIF1-gamma positivity in cancer-associated cases. Anti-HMGCR is associated with statin exposure and necrotizing myopathy but not specifically with malignancy. Anti-NXP-2 is associated with calcinosis and juvenile dermatomyositis. Anti-SAE is associated with dermatomyositis with systemic features but lower malignancy risk.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: U (Underspecified). Verdict: Not uniquely determinable. Key clues: small cell lung cancer, CK 4200 U/L, necrotizing fibers with minimal inflammation, negative anti-SRP. The stem describes immune-mediated necrotizing myopathy (IMNM) pathology, which classically associates with anti-HMGCR or anti-SRP antibodies. While anti-TIF1-gamma strongly links to malignancy-associated dermatomyositis (DM), DM biopsies show perimysial inflammatory infiltrates, not minimal inflammation. The critical absence of skin exam details and statin exposure history creates pathophysiologic ambiguity: should answer selection prioritize the malignancy association (favoring TIF1-gamma) or the IMNM pathology (favoring HMGCR)? This underspecification prevents confident single-best answer identification without unstated assumptions. Medical accuracy issue: the rationale incorrectly conflates TIF1-gamma-associated DM with IMNM pathology, misrepresenting established clinicopathologic correlations. Minimal fix: Explicitly state 'no history of statin use' and 'no heliotrope rash or Gottron papules' in the stem to clarify that malignancy association should be prioritized, or revise biopsy description to include perimysial inflammation consistent with DM.\",\n\"medical_accuracy_score\":   \t\"2\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"U\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U (Underspecified). Verdict: Not uniquely determinable. Key clues: small cell lung cancer, CK 4200 U/L, necrotizing fibers with minimal inflammation, negative anti-SRP. The stem describes immune-mediated necrotizing myopathy (IMNM) pathology, which classically associates with anti-HMGCR or anti-SRP antibodies. While anti-TIF1-gamma strongly links to malignancy-associated dermatomyositis (DM), DM biopsies show perimysial inflammatory infiltrates, not minimal inflammation. The critical absence of skin exam details and statin exposure history creates pathophysiologic ambiguity: should answer selection prioritize the malignancy association (favoring TIF1-gamma) or the IMNM pathology (favoring HMGCR)? This underspecification prevents confident single-best answer identification without unstated assumptions. Medical accuracy issue: the rationale incorrectly conflates TIF1-gamma-associated DM with IMNM pathology, misrepresenting established clinicopathologic correlations. Minimal fix: Explicitly state 'no history of statin use' and 'no heliotrope rash or Gottron papules' in the stem to clarify that malignancy association should be prioritized, or revise biopsy description to include perimysial inflammation consistent with DM.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-007", "question": "A 28-year-old woman at 32 weeks gestation presents with severe headache, visual changes, and right upper quadrant pain. Blood pressure is 178/112 mmHg. Laboratory studies show platelets 62,000/μL, AST 342 U/L, ALT 298 U/L, LDH 890 U/L, creatinine 1.8 mg/dL, and peripheral smear with schistocytes. Urinalysis shows 3+ protein. She receives magnesium sulfate and labetalol. Despite delivery 6 hours later, her platelet count drops to 28,000/μL and creatinine rises to 3.2 mg/dL over the next 48 hours. ADAMTS13 activity returns at 68%. Which of the following is the most appropriate next step in management?", "options": ["Initiate therapeutic plasma exchange", "Administer eculizumab", "Begin rituximab infusion", "Transfuse platelets to maintain count above 50,000/μL", "Continue supportive care with expectant management"], "answer": "B", "answer_index": 1, "explanation": "This patient has pregnancy-associated atypical hemolytic uremic syndrome (aHUS), evidenced by persistent/worsening microangiopathic hemolytic anemia and renal failure after delivery with ADAMTS13 activity >10% (ruling out TTP). Complement-mediated aHUS can be triggered by pregnancy and does not resolve with delivery alone. Eculizumab, a C5 complement inhibitor, is the treatment of choice for aHUS. Plasma exchange is first-line for TTP (ADAMTS13 <10%) but less effective in aHUS. Rituximab targets B cells and is used for autoimmune TTP. Platelet transfusion is relatively contraindicated in TMA. Expectant management risks progressive renal failure.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"The stem presents a classic HELLP syndrome picture (severe hypertension, proteinuria, RUQ pain, AST/ALT in 300s, hemolysis, thrombocytopenia) with expected postpartum nadir (platelets 28k, creatinine 3.2 at 48h). ADAMTS13 >10% rules out TTP but fails to distinguish HELLP from aHUS. Both B (eculizumab for aHUS) and E (supportive care for HELLP) are clinically defensible, requiring an unstated diagnostic assumption. The keyed answer assumes aHUS despite HELLP's far higher prevalence and the atypicality of marked LFT elevation/proteinuria in aHUS. This represents a logical validity failure (multiple defensible answers due to underspecification) and minor medical accuracy issues (misleading clinical representation). Minimal fix: Specify complement studies (e.g., low C3, elevated sC5b-9) and prolonged course (>5 days) to confirm aHUS, or remove HELLP features (normal LFTs, no proteinuria) to isolate aHUS as the diagnosis.\",\"medical_accuracy_score\":   \"3\",\"logical_validity\": false,\"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The stem presents a classic HELLP syndrome picture (severe hypertension, proteinuria, RUQ pain, AST/ALT in 300s, hemolysis, thrombocytopenia) with expected postpartum nadir (platelets 28k, creatinine 3.2 at 48h). ADAMTS13 >10% rules out TTP but fails to distinguish HELLP from aHUS. Both B (eculizumab for aHUS) and E (supportive care for HELLP) are clinically defensible, requiring an unstated diagnostic assumption. The keyed answer assumes aHUS despite HELLP's far higher prevalence and the atypicality of marked LFT elevation/proteinuria in aHUS. This represents a logical validity failure (multiple defensible answers due to underspecification) and minor medical accuracy issues (misleading clinical representation). Minimal fix: Specify complement studies (e.g., low C3, elevated sC5b-9) and prolonged course (>5 days) to confirm aHUS, or remove HELLP features (normal LFTs, no proteinuria) to isolate aHUS as the diagnosis.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-008", "question": "A 14-year-old boy with no significant medical history presents after a witnessed generalized tonic-clonic seizure lasting 2 minutes with spontaneous termination. He reports a 3-month history of early morning myoclonic jerks causing him to drop objects, which he attributed to clumsiness. EEG shows 4-6 Hz generalized polyspike-and-wave discharges with photosensitivity. MRI brain is normal. His father had similar episodes as a teenager that resolved. Which of the following medications should be specifically avoided in this patient?", "options": ["Levetiracetam", "Valproic acid", "Lamotrigine", "Carbamazepine", "Topiramate"], "answer": "D", "answer_index": 3, "explanation": "This patient has juvenile myoclonic epilepsy (JME), characterized by myoclonic jerks (especially morning), generalized tonic-clonic seizures, photosensitivity, and generalized polyspike-and-wave on EEG. Carbamazepine and other sodium channel blockers (phenytoin, oxcarbazepine) can paradoxically worsen myoclonic and absence seizures in genetic generalized epilepsies like JME by enhancing thalamocortical synchronization. Valproic acid is highly effective but avoided in women of childbearing potential due to teratogenicity. Levetiracetam and lamotrigine are appropriate alternatives. Topiramate has broad-spectrum efficacy including in JME.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 14-year-old male with juvenile myoclonic epilepsy (JME) classic triad—early morning myoclonic jerks, generalized tonic-clonic seizure, and EEG showing 4-6 Hz generalized polyspike-and-wave discharges with photosensitivity; normal MRI and family history support genetic generalized epilepsy. The question asks which medication should be specifically avoided. Carbamazepine (D) is uniquely correct: sodium channel blockers worsen myoclonic seizures in JME by enhancing thalamocortical synchronization, making this a critical contraindication. Alternative assessment: Levetiracetam (A) and lamotrigine (C) are appropriate broad-spectrum options; topiramate (E) is effective in JME; valproic acid (B) is actually first-line and highly effective in JME (teratogenicity concern from rationale is irrelevant to this male adolescent patient). No logical flaws: stem provides sufficient discriminators for JME diagnosis, and only one option is contraindicated. Medical accuracy is gold-standard: aligns with ILAE guidelines and board expectations. Minimal fix: None required; item is fully board-ready.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 14-year-old male with juvenile myoclonic epilepsy (JME) classic triad—early morning myoclonic jerks, generalized tonic-clonic seizure, and EEG showing 4-6 Hz generalized polyspike-and-wave discharges with photosensitivity; normal MRI and family history support genetic generalized epilepsy. The question asks which medication should be specifically avoided. Carbamazepine (D) is uniquely correct: sodium channel blockers worsen myoclonic seizures in JME by enhancing thalamocortical synchronization, making this a critical contraindication. Alternative assessment: Levetiracetam (A) and lamotrigine (C) are appropriate broad-spectrum options; topiramate (E) is effective in JME; valproic acid (B) is actually first-line and highly effective in JME (teratogenicity concern from rationale is irrelevant to this male adolescent patient). No logical flaws: stem provides sufficient discriminators for JME diagnosis, and only one option is contraindicated. Medical accuracy is gold-standard: aligns with ILAE guidelines and board expectations. Minimal fix: None required; item is fully board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-009", "question": "A 55-year-old man is admitted to the ICU with septic shock secondary to necrotizing pancreatitis. Despite adequate fluid resuscitation and norepinephrine at 0.5 mcg/kg/min, his MAP remains 58 mmHg. Vasopressin 0.04 units/min is added. Central venous oxygen saturation is 58%, lactate is 6.2 mmol/L, and cardiac index by thermodilution is 2.0 L/min/m². Echocardiogram shows hyperdynamic left ventricle with LVEF 70% and small, underfilled chambers. Which of the following is the most appropriate next intervention?", "options": ["Add dobutamine for inotropic support", "Administer additional crystalloid bolus", "Initiate phenylephrine infusion", "Add epinephrine as third vasopressor", "Begin hydrocortisone 50 mg IV every 6 hours"], "answer": "B", "answer_index": 1, "explanation": "Despite initial resuscitation, the echocardiographic findings of hyperdynamic LV with small, underfilled chambers indicate persistent hypovolemia. The low ScvO2 (58%) and elevated lactate suggest inadequate oxygen delivery. In the setting of distributive shock with evidence of preload deficiency, additional volume resuscitation is indicated before adding further vasopressors. Dobutamine would be inappropriate given the already hyperdynamic state. Phenylephrine causes pure vasoconstriction without inotropy and may worsen cardiac output. Epinephrine could be considered after optimizing preload. Hydrocortisone is indicated for refractory shock but addressing hypovolemia takes priority.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues: septic shock with persistent hypotension (MAP 58 mmHg) despite norepinephrine (0.5 mcg/kg/min) and vasopressin; echo showing hyperdynamic LV (EF 70%) with small, underfilled chambers; ScvO2 58% and lactate 6.2 mmol/L indicating tissue hypoperfusion; cardiac index 2.0 L/min/m². These objective findings establish persistent hypovolemia as the primary problem despite initial fluid resuscitation. Option B (additional crystalloid bolus) is most appropriate per sepsis management hierarchy—preload optimization must precede escalating vasopressors or adding inotropes. Alternatives are correctly less suitable: dobutamine (A) is inappropriate for a hyperdynamic LV; phenylephrine (C) increases afterload without addressing preload; epinephrine (D) is reserved for post-volume optimization; hydrocortisone (E) is for refractory shock after volume/vasopressor optimization. No logical flaws: stem provides clear discriminatory data without contradiction, supporting a single best answer. Medical accuracy: fully consistent with Surviving Sepsis Campaign guidelines and current critical care standards. Minor limitation: 'adequate fluid resuscitation' is subjective but overridden by objective echo data. Minimal fix: none required.\",\"medical_accuracy_score\":   \t\t\t\t\t\t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: septic shock with persistent hypotension (MAP 58 mmHg) despite norepinephrine (0.5 mcg/kg/min) and vasopressin; echo showing hyperdynamic LV (EF 70%) with small, underfilled chambers; ScvO2 58% and lactate 6.2 mmol/L indicating tissue hypoperfusion; cardiac index 2.0 L/min/m². These objective findings establish persistent hypovolemia as the primary problem despite initial fluid resuscitation. Option B (additional crystalloid bolus) is most appropriate per sepsis management hierarchy—preload optimization must precede escalating vasopressors or adding inotropes. Alternatives are correctly less suitable: dobutamine (A) is inappropriate for a hyperdynamic LV; phenylephrine (C) increases afterload without addressing preload; epinephrine (D) is reserved for post-volume optimization; hydrocortisone (E) is for refractory shock after volume/vasopressor optimization. No logical flaws: stem provides clear discriminatory data without contradiction, supporting a single best answer. Medical accuracy: fully consistent with Surviving Sepsis Campaign guidelines and current critical care standards. Minor limitation: 'adequate fluid resuscitation' is subjective but overridden by objective echo data. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-010", "question": "A 7-year-old boy presents with 2 weeks of progressive gait instability and tremor. Examination reveals opsoclonus (chaotic, multidirectional saccadic eye movements), myoclonus, and truncal ataxia. MRI brain and spine are normal. CSF shows mild lymphocytic pleocytosis. CT chest/abdomen/pelvis reveals a paraspinal mass. Urine catecholamines are elevated. Tumor resection is planned. Which of the following additional findings would indicate the WORST long-term neurodevelopmental prognosis despite tumor treatment?", "options": ["Presence of anti-Hu antibodies in serum", "CSF oligoclonal bands with elevated IgG index", "Age less than 3 years at symptom onset", "Tumor histology showing neuroblastoma with MYCN amplification", "Delayed initiation of immunotherapy beyond 4 weeks from diagnosis"], "answer": "C", "answer_index": 2, "explanation": "Opsoclonus-myoclonus-ataxia syndrome (OMS) associated with neuroblastoma has variable neurodevelopmental outcomes. Younger age at onset (particularly <3 years) is paradoxically associated with worse long-term cognitive and behavioral outcomes, likely due to the impact of neuroinflammation on the developing brain during critical periods. While MYCN amplification indicates aggressive tumor biology, it does not correlate with neurological outcomes. Anti-Hu antibodies are rare in pediatric OMS. CSF inflammatory markers and treatment delays affect outcomes but age remains the strongest predictor of neurodevelopmental sequelae.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"The item is logically invalid due to internal contradiction (C). The stem describes a 7-year-old boy with symptom onset 2 weeks prior, making option C (age <3 years at onset) factually impossible and not a plausible 'additional finding.' This disconnect between patient demographics and answer choice creates an unsolvable frame. Medically, the keyed answer's content is accurate and aligns with established OMS-neuroblastoma literature: younger age at onset (<3 years) predicts worse neurodevelopmental outcomes due to neuroinflammatory injury during critical developmental windows, independent of tumor biology (MYCN amplification) or paraneoplastic antibodies (anti-Hu are rare in pediatrics). While CSF oligoclonal bands and treatment delays influence prognosis, age remains the dominant factor. However, the question's construction prevents defensible answer selection. **Fix**: Change the patient's age to 2 years in the stem, or revise option C to 'Current age under 3 years' to eliminate the contradiction while preserving the valid prognostic teaching point.\",\n\"medical_accuracy_score\":    \t\"4\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"C\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is logically invalid due to internal contradiction (C). The stem describes a 7-year-old boy with symptom onset 2 weeks prior, making option C (age <3 years at onset) factually impossible and not a plausible 'additional finding.' This disconnect between patient demographics and answer choice creates an unsolvable frame. Medically, the keyed answer's content is accurate and aligns with established OMS-neuroblastoma literature: younger age at onset (<3 years) predicts worse neurodevelopmental outcomes due to neuroinflammatory injury during critical developmental windows, independent of tumor biology (MYCN amplification) or paraneoplastic antibodies (anti-Hu are rare in pediatrics). While CSF oligoclonal bands and treatment delays influence prognosis, age remains the dominant factor. However, the question's construction prevents defensible answer selection. **Fix**: Change the patient's age to 2 years in the stem, or revise option C to 'Current age under 3 years' to eliminate the contradiction while preserving the valid prognostic teaching point.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 4}]